Universal Cells Inc, based in Seattle, WA, is a pioneering company specializing in the creation of engineered, allogeneic stem cells that can be differentiated into various therapeutic cell types. Utilizing nuclease-free, recombinant Adeno-Associated Virus rAAV gene editing technology, Universal Cells aims to develop universal donor, pluripotent stem cells for the advancement of cell therapy.
With a focus on editing genes essential for immune recognition, Universal Cells is at the forefront of innovation in producing off-the-shelf, stem cell-based products. The company's dedicated teams work on a range of programs from basic discovery to product development, striving to revolutionize the field of regenerative medicine through cutting-edge gene editing methods and stem cell engineering.
Generated from the website